Peoples P Oliver's most recent trade in Yield10 Bioscience Inc was a trade of 1,463 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Yield10 Bioscience Inc | Peoples P Oliver | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 15 Aug 2024 | 1,463 | 12,634 (0%) | 0% | 1.5 | 2,195 | Common Stock |
| Yield10 Bioscience Inc | Peoples Oliver P | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.30 per share. | 15 Feb 2024 | 200,000 | 238,308 (13%) | 11% | 0.3 | 60,000 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.59 per share. | 10 Feb 2023 | 6,298 | 38,304 (2%) | 0% | 3.6 | 22,610 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 10 Aug 2022 | 5,286 | 44,602 (2%) | 0% | 2.7 | 14,166 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 01 Mar 2022 | 1,827 | 49,888 (2%) | 0% | 4.3 | 7,765 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Grant, award, or other acquisition of securities at price $ 3.83 per share. | 10 Feb 2022 | 36,023 | 51,715 (3%) | 2% | 3.8 | 137,968 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. | 01 Sep 2021 | 1,824 | 15,692 (0%) | 0% | 6.7 | 12,239 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres & CEO | Grant, award, or other acquisition of securities at price $ 16.03 per share. | 01 Mar 2021 | 12,429 | 17,516 (1%) | 0% | 16.0 | 199,237 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.77 per share. | 11 Feb 2021 | 866 | 5,087 (0%) | 0% | 22.8 | 19,719 | Common Stock |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 56,000 | 56,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Peoples P Oliver | Director, Pres & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 11 Aug 2020 | 733 | 5,953 (0%) | 0% | 6.5 | 4,801 | Common Stock |